Aflibercept solution

Results for VEGF Trap-Eye ( Aflibercept ophthalmic solution ) from the Phase 3 MYRROR study in myopic choroidal neovascularization (...


Bayer HealthCare has announced that Eylea ( Aflibercept solution for injection ) has been approved by the European Commission (...


Results for VEGF Trap-Eye ( Aflibercept ophthalmic solution; Eylea ) from the phase 3 MYRROR study in myopic choroidal neovascularization...


Bayer HealthCare has announced that Eylea ( Aflibercept solution for injection ), also known as VEGF Trap-Eye, has been approved...


Eylea ( Aflibercept ) injection is a drug for the treatment of patients with neovascular ( wet ) age-related macular...


Regeneron has announced that detailed one-year results from the VIEW 1 and VIEW 2 phase 3 studies of Aflibercept (...